InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
· Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the..
· Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the..
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology..
*Robust Mix Sustained a Strong Start to the Year*
· Net revenues of Euro 1,585 million, up 10.9% versus prior year,..